Albicans

Dr. B Dental Solutions Launches Comprehensive Denture Care Kit for Full, Partial, Implant-Retained and Supported Dentures

Retrieved on: 
Friday, December 23, 2022
Fungus, Palate, Tea tree oil, Dentures, Coconut oil, Mouth, USB, ADA, Stomatitis, Liquid crystal, Candida albicans, Staphylococcus, Aloe, Family, Patient, Actinomyces, Pneumonia, American Dental Association, Vitamin E, Infection, Cleaning, Aloe vera, Xerostomia, Escherichia coli, Albicans, Tongue, Dentistry, Plaster, Streptococcus

Miami, Florida--(Newsfile Corp. - December 23, 2022) - Dr. B Dental Solutions has announced the launch of their care kit for denture wearers.

Key Points: 
  • Miami, Florida--(Newsfile Corp. - December 23, 2022) - Dr. B Dental Solutions has announced the launch of their care kit for denture wearers.
  • There are only three major companies in the US that offer both denture adhesives and denture cleansers, and even less worldwide.
  • Dr. B Dental Solutions is the only company to offer, in addition to superior denture adhesives and dental appliance cleaners, four unique new products with no competition that cater to the same market.
  • The care kit includes the following products:
    The Adhesadent denture adhesive is zinc-free and has no artificial colors or flavors.

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Been Approved by the Australia TGA with a 15 Second SARS-CoV-2 (COVID-19) Kill Time

Retrieved on: 
Friday, October 15, 2021
Biotechnology, Infectious Diseases, Health, Pharmaceutical, Medical Supplies, Itch, View, Staphylococcus aureus, Cell, Severe acute respiratory syndrome coronavirus 2, Private Securities Litigation Reform Act, Nasdaq, TGA, Aviation, Pain, Security (finance), Infection, Tourism, Staphylococcus, Albicans, Marketing, Good Environmental Status, Skin, Fungus, Patient, COVID 19, Scar, Hypochlorous acid, COVID, Economic development, U.S. Securities and Exchange Commission, Forward-looking statement, Bacteria, Pseudomonas aeruginosa, Candida albicans, Patent, Escherichia coli, Aircraft, MRSA, Therapeutic Goods Administration, COO, Partnership, Virus, Medication, COVID-19, Pharmaceutical industry, Hospital, MicroSafe Group, Sonoma Pharmaceuticals, Inc., MICROSAFE GROUP, SONOMA PHARMACEUTICALS, INC.

It is also the only TGA registered hospital grade disinfectant of its kind to be certified by Good Environmental Choice Australia (GECA).

Key Points: 
  • It is also the only TGA registered hospital grade disinfectant of its kind to be certified by Good Environmental Choice Australia (GECA).
  • We are continuously seeking to add to our network of international distributors to increase the reach of Sonoma products worldwide.
  • The MicroSafe Group has operations in several international countries with its head office in Dubai, United Arab Emirates.
  • Sonoma Pharmaceuticals and Microcyn are trademarks or registered trademarks of Sonoma Pharmaceuticals, Inc. All other trademarks and service marks are the property of their respective owners.